Studies on the defense mechanisms of the silkworm, Bombyx mori, against the replication of a nuclear polyhedrosis virus in continuous cell cultures

连续细胞培养中家蚕对抗核型多角体病毒复制的防御机制研究

基本信息

  • 批准号:
    01560066
  • 负责人:
  • 金额:
    $ 1.66万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
  • 财政年份:
    1991
  • 资助国家:
    日本
  • 起止时间:
    1991 至 无数据
  • 项目状态:
    已结题

项目摘要

The investigations on the defense mechanism of the silkworm against the infection of a nuclear polyhedrosis virus (NPV) have been done by means of antigenic stimulation to silkworm larvae or pupae. However, the defense reaction has not been easily demonstrated.The objective of the present study is to investigate the defense mechanism against NPV replication in Bombvx mori continuous cell cultures (S. P. C. Bm36 cells and Bm-N cells).1) The vaccines were made from the NPV (nonoccluded virus) derived from S. P. C. Bm 36 cells by treatment with formalin or irradiation with UV. The vaccine was inoculated to cultured cells 2 and 24 hr, respectively, before the inoculation of NPV. However, the induction of the defense reaction was not shown in both of S. P. C. Bm 36 cells and Bm-N cells.2) The passive immunity, , could not be recognized when the immunized rabbit serum against B. mori NPV (nonroccluded virus) derived from S. P. C. Bm 36 cells was added to the cell culture 24 and 48 hr, respectively, before the inoculation of NPV. In addition, the anti-NPV serum was added to the cell culture immediately and 60 min, respectively, after the inoculation of B. . mori NPV, however, the defense effect of the anti-NPV serum against the replication of the intracellular virus was not demonstrated.3) The interference of nonpermissive virus with the replication of permissive virus in Spodoptera frugiperda cells (IPLB-SF-21AEII) was tested. B. mori NPV which is a nonpermissive against S. frugiperda cell was inoculated to the cell culture, then after 0 and 60 min, respectively, Xestia c-nierum NPV which is permissive against S. frugiperda cell was inoculated. However, the interference of B. mori NPV with X. c-nigrum NPV was not recognized.
关于蚕病毒感染的防御机制(NPV)的防御机制的研究是通过对蚕幼虫或p的抗原刺激进行的。然而,本研究的目的是研究防御反应的目的是调查反对反对NPV复制的防御机制(S. P. C. BM36细胞和BM-N细胞)。1)疫苗是由NPV(非封闭性病毒)生产的。在接种NPV之前,将疫苗分别接种到2和24小时的培养细胞。然而,在S. P. C. Bm 36细胞和BM-N细胞中均未显示防御反应的诱导。另外,在B.接种后,分别将抗NPV血清分别添加到细胞培养和60分钟。但是,未证明抗NPV血清对复制细胞内病毒的复制的防御作用。3)未经允许病毒在Spodoptera frugiperda细胞中的复制(IPLB-SF-21AEII)中的复制中的干扰。 B. mori nPV是针对小链球菌细胞的非允许性的,分别接种了细胞培养,然后在0和60分钟后,Xestia c-Nierum npv接种了Xestia c-Nierum npv,该Xestia c-Nierum npv被接种了针对Frugiperda细胞的允许。然而,尚未认识到X. c-npv npv的干扰。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

FUNAKOSHI Masako其他文献

FUNAKOSHI Masako的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

相似国自然基金

肝胆肿瘤治疗性溶瘤腺病毒疫苗的研制及其临床前应用性探索
  • 批准号:
    82303776
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
基于GMMA递送系统的肺炎克雷伯菌新型OMV疫苗研究
  • 批准号:
    82373779
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
ROS激活ASFV特异性T细胞免疫反应纳米疫苗的制备
  • 批准号:
    22305266
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
基于内质网信号肽耦连多肽文库筛选TAP缺陷诱导肝癌免疫逃逸机制及mRNA疫苗逆转策略的研究
  • 批准号:
    82372798
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
cGAS-STING激活与STAT3抑制双策略聚离子胶束增强放疗肿瘤原位疫苗效应的研究
  • 批准号:
    52303199
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Development of a Cell-Based Assay for Tetanus Vaccine Quality Control
破伤风疫苗质量控制细胞检测方法的开发
  • 批准号:
    10101986
  • 财政年份:
    2024
  • 资助金额:
    $ 1.66万
  • 项目类别:
    Collaborative R&D
Developing an infection-blocking pan-coronavirus vaccine
开发阻断感染的泛冠状病毒疫苗
  • 批准号:
    MR/Y019466/1
  • 财政年份:
    2024
  • 资助金额:
    $ 1.66万
  • 项目类别:
    Research Grant
Vaccine hesitancy DAISI (Digital Animation in Service Improvement): To increase vaccine uptake in ethnic minority perinatal women and young children.
疫苗犹豫 DAISI(服务改进中的数字动画):提高少数民族围产期妇女和幼儿的疫苗接种率。
  • 批准号:
    MR/Z503964/1
  • 财政年份:
    2024
  • 资助金额:
    $ 1.66万
  • 项目类别:
    Research Grant
Bovine herpesvirus 4 as a vaccine platform for African swine fever virus antigens in pigs
牛疱疹病毒 4 作为猪非洲猪瘟病毒抗原的疫苗平台
  • 批准号:
    BB/Y006224/1
  • 财政年份:
    2024
  • 资助金额:
    $ 1.66万
  • 项目类别:
    Research Grant
I-Corps: Translation potential of an efficient method to generate live-attenuated and replication-defective DNA viruses for vaccine development
I-Corps:一种有效方法的转化潜力,可生成用于疫苗开发的减毒活病毒和复制缺陷型 DNA 病毒
  • 批准号:
    2420924
  • 财政年份:
    2024
  • 资助金额:
    $ 1.66万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了